Poppins Secures €5M in Funding to Advance Neurotech Solutions

Poppins, a Paris-based startup specializing in neurotechnology, has successfully raised €5 million in funding to support its innovative solutions.
The funding round was led by Racine, with additional contributions from Bpifrance Patient Autonome fund, Eurazeo, Kurma Partners, BNP Paribas Développement, and Verve Ventures.
With this capital infusion, Poppins plans to expand its operational capabilities and further advance its development initiatives.
Established in 2018 by François Vonthron and Antoine Yuen, both alumni of École Polytechnique in Paris, Poppins focuses on creating medical devices tailored for the treatment of neurodevelopmental disorders, particularly dyslexia. One of its key offerings is a video game application that utilizes rhythmic and auditory stimuli to provide at-home support for individuals undergoing speech therapy.
FinSMEs
28/04/2025